"CRISPR Gene Therapy Shows Promise in Treating Hereditary Angioedema"

Gene therapy using Crispr-Cas9 has shown promising results in treating hereditary angiodema, a genetic disorder causing painful and unpredictable swelling attacks. Patients treated with a single dose of the therapy showed little sign of further symptoms, with one patient experiencing only minor symptoms. The treatment has the potential to provide a permanent cure for this debilitating condition and could also be used to treat other genetic disorders. Larger trials and long-term monitoring are planned to assess the therapy's safety and efficacy.